James Keys and Tunde Ogunlana react to some recent studies into how Ozempic and other GLP-1 type weight loss drugs may be changing not just people’s bodies but also our economy and boosting the GDP.
https://www.washingtonpost.com/health/2025/02/23/ozempic-wegovy-change-life-spending/
https://www.goldmansachs.com/insights/articles/obesity-drugs-are-among-breakthroughs-forecast-GDP
https://www.independent.co.uk/life-style/oprah-winfrey-ozempic-thin-people-realisation-b2684998.html
